BNP PARIBAS FINANCIAL MARKETS - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$907
-99.9%
6,464
+154.6%
0.00%
Q3 2022$1,276,000
+18.8%
2,539
+105.6%
0.00%
Q2 2022$1,074,0001,2350.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Ibex Investors LLC 1,892,593$15,292,0006.10%
GAGNON SECURITIES LLC 281,080$2,271,0000.36%
DISCIPLINED GROWTH INVESTORS INC /MN 2,029,195$16,396,0000.32%
Annandale Capital, LLC 43,532$352,0000.29%
WOODWARD DIVERSIFIED CAPITAL, LLC 23,000$186,0000.12%
IRONWOOD INVESTMENT MANAGEMENT LLC 20,328$164,0000.10%
Claret Asset Management Corp 54,972$444,0000.09%
Migdal Insurance & Financial Holdings Ltd. 890,339$7,194,0000.08%
Shay Capital LLC 47,800$386,0000.08%
ARS Investment Partners, LLC 77,714$628,0000.08%
View complete list of REDHILL BIOPHARMA LTD shareholders